Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

NCT03181815 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Relapse Leukemia

Interventions

DRUG: Cladribine
DRUG: G-CSF
DRUG: Aclarubicin
DRUG: Cytarabine

Sponsor

Sun Yat-sen University